192,897 Shares in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Acquired by Two Sigma Investments LP

Two Sigma Investments LP bought a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 192,897 shares of the company's stock, valued at approximately $7,648,000. Two Sigma Investments LP owned approximately 0.21% of Acadia Healthcare as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also made changes to their positions in the company. Wellington Management Group LLP grew its position in shares of Acadia Healthcare by 0.7% during the fourth quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company's stock worth $465,283,000 after acquiring an additional 76,490 shares during the last quarter. FMR LLC grew its position in Acadia Healthcare by 257.9% during the 4th quarter. FMR LLC now owns 6,230,631 shares of the company's stock worth $247,045,000 after purchasing an additional 4,489,681 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in Acadia Healthcare by 18.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company's stock valued at $126,189,000 after purchasing an additional 486,395 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of Acadia Healthcare by 17.0% in the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock valued at $198,258,000 after buying an additional 454,044 shares during the last quarter. Finally, Madison Avenue Partners LP acquired a new stake in shares of Acadia Healthcare during the fourth quarter worth about $76,339,000.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Royal Bank of Canada decreased their price objective on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. Bank of America decreased their price target on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a report on Friday, February 28th. Barclays dropped their price objective on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a research note on Wednesday, May 14th. Guggenheim initiated coverage on shares of Acadia Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $36.00 target price for the company. Finally, Mizuho dropped their price target on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 14th. Four analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat, Acadia Healthcare presently has an average rating of "Moderate Buy" and an average price target of $47.94.

Acadia Healthcare Price Performance

ACHC traded down $0.28 on Friday, hitting $22.57. 136,431 shares of the company were exchanged, compared to its average volume of 1,711,557. The business's fifty day moving average is $25.21 and its 200 day moving average is $34.43. Acadia Healthcare Company, Inc. has a fifty-two week low of $20.36 and a fifty-two week high of $82.41. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The firm has a market capitalization of $2.08 billion, a P/E ratio of 7.41, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings data on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.05. The firm had revenue of $770.51 million during the quarter, compared to the consensus estimate of $769.90 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Acadia Healthcare's quarterly revenue was up .3% on a year-over-year basis. During the same period last year, the business posted $0.84 EPS. As a group, sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.